Line 50: | Line 50: | ||
{{Heidelberg/panelelement2|d0d0e1|Experts|https://static.igem.org/mediawiki/2017/5/5d/T--Heidelberg--2017_HP_Integrated.png|https://2017.igem.org/Team:Heidelberg/Interviews| | {{Heidelberg/panelelement2|d0d0e1|Experts|https://static.igem.org/mediawiki/2017/5/5d/T--Heidelberg--2017_HP_Integrated.png|https://2017.igem.org/Team:Heidelberg/Interviews| | ||
− | Colololololololololo lolololo lolo lo lol ololololo lolololololololololo lolololol olololo lolololololololo loloololo lolaborations.|Expert Interviews | + | Colololololololololo lolololo lolo lo lol ololololo lolololololololololo lolololol olololo lolololololololo loloololo lolaborations. |
+ | |Expert Interviews | ||
}} | }} | ||
Line 81: | Line 82: | ||
{{Heidelberg/templateus/Heading|Human Practices - Gold Medal Criteria}} | {{Heidelberg/templateus/Heading|Human Practices - Gold Medal Criteria}} | ||
− | {{#tag:html|<div style="position: relative; top: -70px; padding: 0 !important; margin: 0 !important;"> | + | {{#tag:html| |
+ | <div style="position: relative; top: -70px; padding: 0 !important; margin: 0 !important;"> | ||
{{Heidelberg/overviewpanel2|ffdb4d| | {{Heidelberg/overviewpanel2|ffdb4d| | ||
Line 90: | Line 92: | ||
{{Heidelberg/panelelement2|ffdb4d|SafetyNet|https://static.igem.org/mediawiki/2017/1/17/T--Heidelberg--2017_Connections_black.png|https://2017.igem.org/Team:Heidelberg/Collaborations| | {{Heidelberg/panelelement2|ffdb4d|SafetyNet|https://static.igem.org/mediawiki/2017/1/17/T--Heidelberg--2017_Connections_black.png|https://2017.igem.org/Team:Heidelberg/Collaborations| | ||
− | Colololololololololo lolololo lolo lo lol ololololo lolololololololololo lolololol olololo lolololololololo loloololo lolaborations.|More on our SafetyNet | + | Colololololololololo lolololo lolo lo lol ololololo lolololololololololo lolololol olololo lolololololololo loloololo lolaborations. |
+ | |More on our SafetyNet | ||
}} | }} | ||
Line 104: | Line 107: | ||
+ | }} | ||
}} | }} | ||
Revision as of 01:12, 1 November 2017
Human Practices
Overview
Successful in vivo directed evolution by PREDCEL and PACE requires the thorough consideration of experimental parameters, e.g. phage propagation times, culture dilution rates and inducer/inhibitor concentrations. We employed extensive ODE-based and stochastic modeling to identify the most sensitive parameters and adapt our experiments accordingly. First, we calibrated our models using phage propagation experiments from our wet lab complemented with literature data. Simulations showed that the phage titer is highly sensitive to culture dilution rates. We simulated batch times and transfer volumes for PREDCEL and corresponding flow rates for PACE to determine optimized conditions for gene pool selection while avoiding phage washout. We also estimated phage titer monitoring intervals for cost/labor efficient QC as well as inducer/inhibitor concentrations required to express the required mutagenic polymerases. Finally, provide a web-based, fully interactive modeling platform, not only extensively employed by our wet lab, but highly informs future iGEM teams building on our work.
Human Practices - Silver Medal Criteria
Human Practices - Gold Medal Criteria